Literature DB >> 27903532

Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs.

Marcus A F Corat1,2, Heinrich Schlums3, Chuanfeng Wu1, Jakob Theorell3, Diego A Espinoza1, Stephanie E Sellers1, Danielle M Townsley1, Neal S Young1, Yenan T Bryceson3,4, Cynthia E Dunbar1, Thomas Winkler1.   

Abstract

Natural killer (NK) cells have long been considered short-lived effectors of innate immunity. However, recent animal models and human studies suggest that subsets of NK cells have adaptive features. We investigate clonal relationships of various NK-cell subsets, including the adaptive population, by taking advantage of naturally occurring X-linked somatic PIGA mutations in hematopoietic stem and progenitor cells (HSPCs) from patients with paroxysmal nocturnal hemoglobinuria (PNH). The affected HSPCs and their progeny lack expression of glycosylphosphatidylinositol (GPI) anchors on their cell surface, allowing quantification of PIGA-mutant (GPI-negative) HSPC-derived peripheral blood cell populations. The fraction of GPI-negative cells within the CD56dim NK cells was markedly lower than that of neutrophils and the CD56bright NK-cell compartments. This discrepancy was most prominent within the adaptive CD56dim NK-cell population lacking PLZF expression. The functional properties of these adaptive NK cells were similar in PNH patients and healthy individuals. Our findings support the existence of a long-lived, adaptive NK-cell population maintained independently from GPIposCD56dim.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27903532      PMCID: PMC5383870          DOI: 10.1182/blood-2016-08-734285

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

Authors:  Bree Foley; Sarah Cooley; Michael R Verneris; Michelle Pitt; Julie Curtsinger; Xianghua Luo; Sandra Lopez-Vergès; Lewis L Lanier; Daniel Weisdorf; Jeffrey S Miller
Journal:  Blood       Date:  2011-12-16       Impact factor: 22.113

2.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

3.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

4.  A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells.

Authors:  Aharon G Freud; Brian Becknell; Sameek Roychowdhury; Hsiaoyin C Mao; Amy K Ferketich; Gerard J Nuovo; Tiffany L Hughes; Trent B Marburger; John Sung; Robert A Baiocchi; Martin Guimond; Michael A Caligiuri
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

Review 5.  Innate or adaptive immunity? The example of natural killer cells.

Authors:  Eric Vivier; David H Raulet; Alessandro Moretta; Michael A Caligiuri; Laurence Zitvogel; Lewis L Lanier; Wayne M Yokoyama; Sophie Ugolini
Journal:  Science       Date:  2011-01-07       Impact factor: 47.728

6.  Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults.

Authors:  Charles T Lutz; Anush Karapetyan; Ahmad Al-Attar; Brent J Shelton; Kimberly J Holt; Jason H Tucker; Steven R Presnell
Journal:  J Immunol       Date:  2011-03-14       Impact factor: 5.422

7.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

8.  In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection.

Authors:  Yan Zhang; Diana L Wallace; Catherine M de Lara; Hala Ghattas; Becca Asquith; Andrew Worth; George E Griffin; Graham P Taylor; David F Tough; Peter C L Beverley; Derek C Macallan
Journal:  Immunology       Date:  2007-03-07       Impact factor: 7.397

9.  Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection.

Authors:  Joseph C Sun; Joshua N Beilke; Natalie A Bezman; Lewis L Lanier
Journal:  J Exp Med       Date:  2011-01-24       Impact factor: 14.307

10.  Adaptive immune features of natural killer cells.

Authors:  Joseph C Sun; Joshua N Beilke; Lewis L Lanier
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

View more
  16 in total

1.  GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.

Authors:  Moonjung Jung; Stefan Cordes; Jizhong Zou; Shiqin J Yu; Xavi Guitart; So Gun Hong; Vinh Dang; Elaine Kang; Flavia S Donaires; Sergio A Hassan; Maher Albitar; Amy P Hsu; Steven M Holland; Dennis D Hickstein; Danielle Townsley; Cynthia E Dunbar; Thomas Winkler
Journal:  Blood Adv       Date:  2018-12-11

2.  Orphan NKs! The mystery of the self-renewing NK cells.

Authors:  Kate Stringaris
Journal:  Blood       Date:  2017-04-06       Impact factor: 22.113

3.  Adaptive NK cell reconstitution is associated with better clinical outcomes.

Authors:  Frank Cichocki; Emily Taras; Flavia Chiuppesi; John E Wagner; Bruce R Blazar; Claudio Brunstein; Xianghua Luo; Don J Diamond; Sarah Cooley; Daniel J Weisdorf; Jeffrey S Miller
Journal:  JCI Insight       Date:  2019-01-24

4.  Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells.

Authors:  Heinrich Schlums; Moonjung Jung; Hongya Han; Jakob Theorell; Venetia Bigley; Samuel C C Chiang; David S J Allan; Jan K Davidson-Moncada; Rachel E Dickinson; Tim D Holmes; Amy P Hsu; Danielle Townsley; Thomas Winkler; Weixin Wang; Pål Aukrust; Ingvild Nordøy; Katherine R Calvo; Steve M Holland; Matthew Collin; Cynthia E Dunbar; Yenan T Bryceson
Journal:  Blood       Date:  2017-02-16       Impact factor: 22.113

Review 5.  The Broad Spectrum of Human Natural Killer Cell Diversity.

Authors:  Aharon G Freud; Bethany L Mundy-Bosse; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-11-21       Impact factor: 31.745

6.  The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation.

Authors:  Tim D Holmes; Ram Vinay Pandey; Eric Y Helm; Heinrich Schlums; Hongya Han; Tessa M Campbell; Theodore T Drashansky; Samuel Chiang; Cheng-Ying Wu; Christine Tao; Moneef Shoukier; Eva Tolosa; Sandra Von Hardenberg; Miao Sun; Christian Klemann; Rebecca A Marsh; Colleen M Lau; Yin Lin; Joseph C Sun; Robert Månsson; Frank Cichocki; Dorina Avram; Yenan T Bryceson
Journal:  Sci Immunol       Date:  2021-03-12

7.  CMV Triplex Vaccine to Enhance Adaptive NK and T-cell Reconstitution After Autologous Hematopoietic Cell Transplantation.

Authors:  Armin Rashidi; Corinna La Rosa; Julie Curtsinger; Qing Cao; Qiao Zhou; Chetan Raj Lingaraju; Daniel J Weisdorf; Frank Cichocki; Jeffrey S Miller; Don J Diamond
Journal:  Transplant Cell Ther       Date:  2022-03-08

Review 8.  Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell "missing self" recognition.

Authors:  Karl-Johan Malmberg; Ebba Sohlberg; Jodie P Goodridge; Hans-Gustaf Ljunggren
Journal:  Immunogenetics       Date:  2017-07-11       Impact factor: 2.846

9.  Clonal expansion and compartmentalized maintenance of rhesus macaque NK cell subsets.

Authors:  Chuanfeng Wu; Diego A Espinoza; Samson J Koelle; Di Yang; Lauren Truitt; Heinrich Schlums; Bernard A Lafont; Jan K Davidson-Moncada; Rong Lu; Amitinder Kaur; Quirin Hammer; Brian Li; Sandhya Panch; David A Allan; Robert E Donahue; Richard W Childs; Chiara Romagnani; Yenan T Bryceson; Cynthia E Dunbar
Journal:  Sci Immunol       Date:  2018-11-02

Review 10.  Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs.

Authors:  Cristina Capuano; Chiara Pighi; Simone Battella; Davide De Federicis; Ricciarda Galandrini; Gabriella Palmieri
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.